| Literature DB >> 25130296 |
John J Zaunders1, Yves Lévy2, Nabila Seddiki3.
Abstract
Interleukin-7 is a non-redundant growth, differentiation and survival factor for human T lymphocytes. Most circulating, mature T cells express the receptor for IL-7, but not all. Importantly, CD4 Tregs express greatly reduced levels of IL-7R compared to conventional CD4 T cells, presenting an opportunity to selectively target the latter cells with either more IL-7 to boost responses, or to block IL-7 signalling to limit responses. This article reviews what is known about regulation of IL-7R expression, and recent progress in therapeutic approaches related to IL-7 and its receptor.Entities:
Keywords: IL-7R therapy; T cell
Mesh:
Substances:
Year: 2014 PMID: 25130296 DOI: 10.1016/j.cytogfr.2014.07.012
Source DB: PubMed Journal: Cytokine Growth Factor Rev ISSN: 1359-6101 Impact factor: 7.638